Evonik Industries AG (EVK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evonik Industries AG (EVK) has a cash flow conversion efficiency ratio of 0.075x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€612.00 Million ≈ $715.49 Million USD) by net assets (€8.17 Billion ≈ $9.56 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evonik Industries AG - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Evonik Industries AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Evonik Industries AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evonik Industries AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SRF Limited
NSE:SRF
|
0.080x |
|
Sibanye Stillwater Ltd
JSE:SSW
|
0.194x |
|
Compañía de Minas Buenaventura S.A.A
F:MBU
|
0.052x |
|
BRENNTAG SE UNSP.ADR/020
F:BNRA
|
0.076x |
|
Pilgrims Pride Corp
NASDAQ:PPC
|
0.079x |
|
AptarGroup Inc
NYSE:ATR
|
0.068x |
|
Full Truck Alliance Co Ltd ADR
NYSE:YMM
|
0.072x |
|
Hyundai Autoever Corp
KO:307950
|
0.082x |
Annual Cash Flow Conversion Efficiency for Evonik Industries AG (2013–2025)
The table below shows the annual cash flow conversion efficiency of Evonik Industries AG from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €8.17 Billion ≈ $9.56 Billion |
€1.44 Billion ≈ $1.69 Billion |
0.177x | -6.22% |
| 2024-12-31 | €9.10 Billion ≈ $10.64 Billion |
€1.71 Billion ≈ $2.00 Billion |
0.188x | +6.12% |
| 2023-12-31 | €8.99 Billion ≈ $10.51 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.177x | +18.86% |
| 2022-12-31 | €11.06 Billion ≈ $12.93 Billion |
€1.65 Billion ≈ $1.93 Billion |
0.149x | -22.94% |
| 2021-12-31 | €9.37 Billion ≈ $10.96 Billion |
€1.81 Billion ≈ $2.12 Billion |
0.194x | -9.18% |
| 2020-12-31 | €8.10 Billion ≈ $9.47 Billion |
€1.73 Billion ≈ $2.02 Billion |
0.213x | +46.25% |
| 2019-12-31 | €9.06 Billion ≈ $10.59 Billion |
€1.32 Billion ≈ $1.54 Billion |
0.146x | -35.17% |
| 2018-12-31 | €7.83 Billion ≈ $9.15 Billion |
€1.76 Billion ≈ $2.06 Billion |
0.225x | +9.15% |
| 2017-12-31 | €7.53 Billion ≈ $8.80 Billion |
€1.55 Billion ≈ $1.81 Billion |
0.206x | -9.73% |
| 2016-12-31 | €7.75 Billion ≈ $9.06 Billion |
€1.77 Billion ≈ $2.07 Billion |
0.228x | -12.26% |
| 2015-12-31 | €7.58 Billion ≈ $8.86 Billion |
€1.97 Billion ≈ $2.30 Billion |
0.260x | +59.17% |
| 2014-12-31 | €6.52 Billion ≈ $7.62 Billion |
€1.07 Billion ≈ $1.25 Billion |
0.163x | +5.91% |
| 2013-12-31 | €6.84 Billion ≈ $7.99 Billion |
€1.05 Billion ≈ $1.23 Billion |
0.154x | -- |
About Evonik Industries AG
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent… Read more